Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States

Circulation

Volumn 126, Issue 19, 2012, Pages 2293-2301

  Goldstein, Benjamin A ^a   Arce, Cristina M ^b   Hlatky, Mark A ^b,c   Turakhia, Mintu ^c,d   Setoguchi, Soko ^e   Winkelmayer, Wolfgang C ^b  

^a Division of General Medical Disciplines   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Cardiovascular Medicine   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

atrial fibrillation; dialysis; incidence; kidney failure chronic; mortality

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; BRAIN ISCHEMIA; ETHNICITY; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEMODIALYSIS PATIENT; HISPANIC; HUMAN; INCIDENCE; MALE; MORTALITY; PRIORITY JOURNAL; RACE; UNITED STATES;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MEDICARE; MULTIVARIATE ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; STROKE; UNITED STATES;

EID: 84868552524     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.099606     Document Type: Article

References (47)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18-e209.
2. Go AS. The epidemiology of atrial fibrillation in elderly persons: The tip of the iceberg. Am J Geriatr Cardiol. 2005;14:56-61.
3. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata Preventive Medicine Study. Am Heart J. 2009; 158:629-636.
4. McManus DD, Corteville DC, Shlipak MG, Whooley MA, Ix JH. Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul study). Am J Cardiol. 2009;104:1551-1555.
5. Baber U, Howard VJ, Halperin JL, Soliman EZ, Zhang X, McClellan W, Warnock DG, Muntner P. Association of chronic kidney disease with atrial fibrillation among adults in the United States: Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Circ Arrhythm Electrophysiol. 2011;4:26-32.
6. Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, Ojo A, Teal VL, Jensvold NG, Robinson NL, Dries DL, Bazzano L, Mohler ER, Wright JT, Feldman HI. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J. 2010;159:1102-1107.
7. Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY, Soliman EZ, Astor BC, Coresh J. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:2946-2953.
8. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011;22:349-357.
9. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol. 2003;4:1.
10. Wizemann V, Tong L, Satayathum S, Disney A, Akiba T, Fissell RB, Kerr PG, Young EW, Robinson BM. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int. 2010;77:1098-1106.
11. Yan Y, Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Comorbidity indices to predict mortality from medicare data: results from the National Registry of Atrial Fibrillation. Med Care. 2005;43:1073-1077. (Pubitemid 41587592)
12. Choudhry NK, Soumerai SB, Normand SL, Ross-Degnan D, Laupacis A, Anderson GM. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med. 2006;119: 607-615. (Pubitemid 44055890)
13. Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ. 2006;332: 141-145.
14. Lentine KL, Schnitzler MA, Abbott KC, Li L, Xiao H, Burroughs TE, Takemoto SK, Willoughby LM, Gavard JA, Brennan DC. Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol. 2006;1:288-296.
15. Piccini JP, Hammill BG, Sinner MF, Jensen PN, Hernandez AF, Heckbert SR, Benjamin EJ, Curtis LH. Incidence and prevalence of atrial fibril-lation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes. 2012;5:85-93.
16. Lentine KL, Schnitzler MA, Abbott KC, Bramesfeld K, Buchanan PM, Brennan DC. Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol. 2009;4:1213-1221.
17. Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using International Classification of Diseases, Revisions 9 and 10. Stroke. 2005;36:1776-1781. (Pubitemid 41098778)
18. Frost L, Vestergaard P. Caffeine and risk of atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am J Clin Nutr. 2005;81: 578-582.
19. Reker DM, Hamilton BB, Duncan PW, Yeh SC, Rosen A. Stroke: who's counting what? J Rehabil Res Dev. 2001;38:281-289.
20. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541-554. (Pubitemid 9067879)
21. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
22. Sarkar SR, Kotanko P, Levin NW. Interdialytic weight gain: implications in hemodialysis patients. Semin Dial. 2006;19:429-433. (Pubitemid 44393567)
23. Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial. 2009;22:636-643.
24. Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007;115:135-143. (Pubitemid 46136515)
25. McIntyre CW. Calcium balance during hemodialysis. Semin Dial. 2008; 21:38-42.
26. Korantzopoulos PG, Goudevenos JA. Atrial fibrillation in end-stage renal disease: an emerging problem. Kidney Int. 2009;76:247-249.
27. Alonso A, Agarwal SK, Soliman EZ, Ambrose M, Chamberlain AM, Prineas RJ, Folsom AR. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158:111-117.
28. Borzecki AM, Bridgers DK, Liebschutz JM, Kader B, Kazis LE, Berlowitz DR. Racial differences in the prevalence of atrial fibrillation among males. J Natl Med Assoc. 2008;100:237-245. (Pubitemid 351281177)
29. Ruo B, Capra AM, Jensvold NG, Go AS. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol. 2004;43:429-435. (Pubitemid 38167704)
30. Marcus GM, Alonso A, Peralta CA, Lettre G, Vittinghoff E, Lubitz SA, Fox ER, Levitzky YS, Mehra R, Kerr KF, Deo R, Sotoodehnia N, Akylbekova M, Ellinor PT, Paltoo DN, Soliman EZ, Benjamin EJ, Heckbert SR. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation. 2010;122:2009-2015.
31. Peralta CA, Shlipak MG, Fan D, Ordonez J, Lash JP, Chertow GM, Go AS. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006;17:2892-2899. (Pubitemid 44484680)
32. Ricardo AC, Lash JP, Fischer MJ, Lora CM, Budoff M, Keane MG, Kusek JW, Martinez M, Nessel L, Stamos T, Ojo A, Rahman M, Soliman EZ, Yang W, Feldman HI, Go AS. Cardiovascular disease among Hispanics and non-Hispanics in the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol. 2011;6:2121-2131.
33. Rodriguez CJ, Diez-Roux AV, Moran A, Jin Z, Kronmal RA, Lima J, Homma S, Bluemke DA, Barr RG. Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2010;55:234-242.
34. Bush D, Martin LW, Leman R, Chandler M, Haywood LJ. Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. J Natl Med Assoc. 2006;98:330-339. (Pubitemid 43352521)
35. Thomas KL, Hernandez AF, Dai D, Heidenreich P, Fonarow GC, Peterson ED, Yancy CW. Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. Am Heart J. 2011;161:746-754.
36. Nguyen HT, Stack AG. Ethnic disparities in cardiovascular risk factors and coronary disease prevalence among individuals with chronic kidney disease: findings from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2006;17:1716-1723. (Pubitemid 43794675)
37. Mitchell BD, Hazuda HP, Haffner SM, Patterson JK, Stern MP. Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart study. Circulation. 1991;83:45-51.
38. Miyasaka Y, Barnes ME, Bailey KR, Cha SS, Gersh BJ, Seward JB, Tsang TS. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007;49:986-992.
39. Agodoa L, Eggers P. Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans. Semin Dial. 2007;20: 577-585.
40. Frankenfield DL, Rocco MV, Roman SH, McClellan WM. Survival advantage for adult hispanic hemodialysis patients? Findings from the End-Stage Renal Disease Clinical Performance Measures project. J Am Soc Nephrol. 2003;14:180-186. (Pubitemid 36026308)
41. Pei YP, Greenwood CM, Chery AL, Wu GG. Racial differences in survival of patients on dialysis. Kidney Int. 2000;58:1293-1299.
42. Murthy BV, Molony DA, Stack AG. Survival advantage of hispanic patients initiating dialysis in the United States is modified by race. J Am Soc Nephrol. 2005;16:782-790. (Pubitemid 41725115)
43. Robinson BM, Joffe MM, Pisoni RL, Port FK, Feldman HI. Revisiting survival differences by race and ethnicity among hemodialysis patients: the dialysis outcomes and practice patterns study. J Am Soc Nephrol. 2006;17:2910-2918. (Pubitemid 44484682)
44. Price DA, Owen WF Jr. African-Americans on maintenance dialysis: a review of racial differences in incidence, treatment, and survival. Adv Ren Replace Ther. 1997;4:3-12. (Pubitemid 27030451)
45. Mesler DE, McCarthy EP, Byrne-Logan S, Ash AS, Moskowitz MA. Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment? Am J Med. 1999;106:300-306. (Pubitemid 29153407)
46. Gibbs HR, Swafford J, Nguyen HD, Ewer MS, Ali MK. Postoperative atrial fibrillation in cancer surgery: preoperative risks and clinical outcome. J Surg Oncol. 1992;50:224-227.
47. Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011;306:2248-2254.